Albert David Ltd. — Investor Relations & Filings
Albert David Ltd. specializes in the manufacturing and marketing of pharmaceutical formulations, infusions, and herbal preparations. The company’s product portfolio encompasses a wide range of therapeutic segments, including anti-infectives, gastrointestinal agents, and ophthalmic solutions. A significant area of expertise lies in the production of large and small volume parenterals and specialized placenta extract-based treatments used for tissue regeneration and wound healing. The organization maintains advanced production facilities and focuses on research and development to support its diverse clinical offerings. Its operations serve a broad spectrum of healthcare needs across various global markets, emphasizing quality control and technical precision in its manufacturing processes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-07 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-04-07 | English | |
| Trading Window | 2026-03-23 | English | |
| Copy of Newspaper Publication | 2026-03-13 | English | |
| Copy of Newspaper Publication | 2026-03-11 | English | |
| Cessation | 2026-03-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 42199383 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-07 | English | ||
| 42201053 | Disclosure under SEBI Takeover Regulations | 2026-04-07 | English | ||
| 42205449 | Trading Window | 2026-03-23 | English | ||
| 42196147 | Copy of Newspaper Publication | 2026-03-13 | English | ||
| 42172583 | Copy of Newspaper Publication | 2026-03-11 | English | ||
| 42177873 | Cessation | 2026-03-10 | English | ||
| 42188184 | Copy of Newspaper Publication | 2026-02-12 | English | ||
| 42210300 | Integrated Filing- Financial | 2026-02-11 | English | ||
| 42211303 | Outcome of Board Meeting | 2026-02-11 | English | ||
| 42209826 | Change in Management | 2026-01-17 | English | ||
| 42233902 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-01-05 | English | ||
|
2025
4 filings
| |||||
| 42232770 | Trading Window | 2025-12-22 | English | ||
| 42233724 | Trading Window | 2025-12-22 | English | ||
| 42211154 | Change in Director(s) | 2025-12-18 | English | ||
| 42211251 | Change in Management | 2025-12-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOVIE INC.
Develops drug therapies for neurological disorders and adva…
|
BIVI | US | Manufacturing |
|
BioXcel Therapeutics, Inc.
Biopharmaceutical company using AI to develop drugs for neu…
|
BTAI | US | Manufacturing |
|
Bioxel Pharma Inc.
Develops, manufactures, and markets taxane APIs, essential …
|
— | CA | Manufacturing |
|
BIOXYNE LIMITED
Life sciences company focused on probiotics, medicinal cann…
|
BXN | AU | Manufacturing |
|
B&K CORPORATION LIMITED
Innovative biopharma developing PDGF therapeutic drugs for …
|
2396 | HK | Manufacturing |
|
Black Diamond Therapeutics, Inc.
Develops precision oncology therapies targeting families of…
|
BDTX | US | Manufacturing |
|
BLAU FARMACÊUTICA S.A.
Multinational producer of high-complexity medications for h…
|
— | BR | Manufacturing |
|
Bliss GVS Pharma Limited
Global leader in suppository and pessary production for eme…
|
BLISSGVS | IN | Manufacturing |
|
Blis Technologies Limited
Develops and commercializes patented probiotic strains for …
|
BLT | NZ | Manufacturing |
|
Bloomage Biotechnology Corporation Limited
Global leader in hyaluronic acid and bioactive substance re…
|
688363 | CN | Manufacturing |
Albert David Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60428/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60428 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60428 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60428 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60428}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Albert David Ltd. (id: 60428)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.